Targeted
In this section you will find Therapeutics Line of Treatment Targeted market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
12 Item(s)
per page
-
Genomic Sequencing Technologies for Medicine: Market Prospects 2011-2021
€1,968.00Published by Visiongain on May 3rd, 2011how you can discover commercial opportunities in genomics How will the genomic sequencing market develop this decade? Our new report shows you that industry and market’s revenue potential from 2011... Learn More -
Therapeutic Monoclonal Antibodies Markets
€1,699.00Published by TriMark Publications LLC on Jun 1st, 2009With a unique ability to specifically target diseased cells while leaving healthy cells unaffected, monoclonal antibodies can serve to diagnose and treat a wide range of medical conditions. Learn More -
Therapeutic Monoclonal Antibodies Report 2008-2023
€1,739.00Published by Visiongain on Jul 25th, 2008This report examines the market for monoclonal antibodies critically, through comprehensive primary and secondary research. In addition to consultation with experts in industry - including full interview transcripts - this research involved a detailed study of relevant documents, industrial reports and current developments. Learn More -
Cancer Antibodies: Competitive Positioning for Success
€1,950.00Published by BioSeeker Group on Jun 3rd, 2008This report is written for you to identify your competition and understand which targeting strategies are at work within antibody drug development. It allows you to pin-point which competitors drugs’ clinical out-come may have bearing on your own drug development and who are developing sequels to blockbuster drugs. This report also helps you to locate white-spots in the competitive landscape, giving you little or no competition. Conversely it may reveal unexpected competition for you. Learn More -
The Deployment of Antibody Technologies for the Advancement of Cancer Therapeutics
€2,300.00Published by BioSeeker Group on Apr 1st, 2008The discovery of new cancer therapeutics has seen a significant shift towards biologicals as an alternative to small molecule drugs. Targeted biologics utilizing monoclonal antibody-based technologies have rapidly developed into one of the major market segments of the pharmaceutical industry. Learn More -
The Complete Guide to Targeted Therapies in Oncology: A World Review
€4,950.00Published by BioSeeker Group on Dec 19th, 2006In this comprehensive report covering targeted therapies in oncology, BioSeeker Group has analyzed apoptopic agents, protein kinase inhibitors, anti-angiogenic and vascular targeting agents, immunostimulators, antibodies and vaccines in oncology. Learn More -
Competitive Outlook on Antiangiogenesis and Vascular Targeting in Oncology
€1,950.00Published by BioSeeker Group on Oct 9th, 2006Assess opportunities and risks for the continued development of anti-angiogenic and vascular targeting agents in five major cancer indications. Learn More -
Lymphoma - A Therapeutic & Competitive Insight
€1,950.00Published by BioSeeker Group on May 29th, 2006Gain insight into the current challenges and commercial opportunities associated with lymphoma therapy Learn More -
Complete Target Atlas in Oncology Drug Development: From Tumor to Targeted Therapy
€7,950.00Published by BioSeeker Group (Multi-report (See individual release dates))This report is an open landscape of resources to build, fuel, and drive your scientific competitive vehicle for the advancement of cancer drugs. It will assist you in lead commercial analysis and product strategy thinking to build and nurture current and future portfolio of drug candidates and R&D alliances. Learn More -
Target Atlas in Oncology Drug Development: Targeted Therapies
€5,750.00Published by BioSeeker Group (Multi-report (See individual release dates))This report is an open landscape of resources to build, fuel, and drive your scientific competitive vehicle for the advancement of cancer drugs. It will assist you in lead commercial analysis and product strategy thinking to build and nurture current and future portfolio of drug candidates and R&D alliances. Learn More -
Triple Target Atlas in Oncology Drug Development
€3,450.00Published by BioSeeker Group (Multi-report (See individual release dates))This report is an open landscape of resources to build, fuel, and drive your scientific competitive vehicle for the advancement of cancer drugs. It will assist you in lead commercial analysis and product strategy thinking to build and nurture current and future portfolio of drug candidates and R&D alliances. Learn More -
Target Atlas in Oncology Drug Development: Major Tumor Types
€4,600.00Published by BioSeeker Group (Multi-report (See individual release dates))This report is an open landscape of resources to build, fuel, and drive your scientific competitive vehicle for the advancement of cancer drugs. It will assist you in lead commercial analysis and product strategy thinking to build and nurture current and future portfolio of drug candidates and R&D alliances. Learn More
12 Item(s)
per page